Axial mitochondrial myopathy in a patient with rapidly progressive adult-onset scoliosis

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Hiniker, Annie ^a   Wong, Lee Jun ^b   Berven, Sigurd ^a   Truong, Cavatina K ^b   Adesina, Adekunle M ^b   Margeta, Marta ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adult scoliosis; Camptocormia; Mitochondrial myopathy; MtDNA

Indexed keywords

MITOCHONDRIAL DNA;

AGED; CASE REPORT; DISEASE COURSE; ELECTRON TRANSPORT; FEMALE; GENETICS; HUMAN; METABOLISM; MITOCHONDRIAL MYOPATHIES; PARASPINAL MUSCLE; PATHOLOGY; SCOLIOSIS;

AGED; DISEASE PROGRESSION; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; FEMALE; HUMANS; MITOCHONDRIAL MYOPATHIES; PARASPINAL MUSCLES; SCOLIOSIS;

EID: 84965084627     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/s40478-014-0137-3     Document Type: Article

References (25)

1. Lenoir T, Guedj N, Boulu P, Guigui P, Benoist M: Camptocormia: the bent spine syndrome, an update. Eur Spine J 2010, 19(8):1229-1237. [ 10.1007/s00586-010-1370-5 ] 10.1007/s00586-010-1370-5
2. Wrede A, Margraf NG, Goebel HH, Deuschl G, Schulz-Schaeffer WJ: Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinson's disease. Acta Neuropathol 2012, 123(3):419-432. doi:10.1007/s00401-011-0927-7 10.1007/s00401-011-0927-7
3. Tiple D, Fabbrini G, Colosimo C, Ottaviani D, Camerota F, Defazio G, Berardelli A: Camptocormia in Parkinson disease: an epidemiological and clinical study. J Neurol Neurosurg Psychiatry 2009, 80(2):145-148. doi:10.1136/jnnp.2008.150011 10.1136/jnnp.2008.150011
4. Gdynia HJ, Sperfeld AD, Unrath A, Ludolph AC, Sabolek M, Storch A, Kassubek J: Histopathological analysis of skeletal muscle in patients with Parkinson's disease and 'dropped head'/'bent spiné syndrome. Parkinsonism Relat Disord 2009, 15(9):633-639. doi:10.1016/j.parkreldis.2009.06.003 10.1016/j.parkreldis.2009.06.003
5. Gomez-Puerta JA, Peris P, Grau JM, Martinez MA, Guanabens N: Camptocormia as a clinical manifestation of mitochondrial myopathy. Clin Rheumatol 2007, 26(6):1017-1019. doi:10.1007/s10067-006-0259-5 10.1007/s10067-006-0259-5
6. Mahjneh I, Marconi G, Paetau A, Saarinen A, Salmi T, Somer H: Axial myopathy-an unrecognised entity. J Neurol 2002, 249(6):730-734. doi:10.1007/s00415-002-0701-9 10.1007/s00415-002-0701-9
7. Serratrice G: Axial myopathies: an elderly disorder. Acta myologica 2007, 26(1):11-13.
8. Sakiyama Y, Okamoto Y, Higuchi I, Inamori Y, Sangatsuda Y, Michizono K, Watanabe O, Hatakeyama H, Goto Y, Arimura K, Takashima H: A new phenotype of mitochondrial disease characterized by familial late-onset predominant axial myopathy and encephalopathy. Acta Neuropathol 2011, 121(6):775-783. doi:10.1007/s00401-011-0818-y 10.1007/s00401-011-0818-y
9. Kirby DM, Thorburn DR, Turnbull DM, Taylor RW: Biochemical assays of respiratory chain complex activity. Methods Cell Biol 2007, 80: 93-119. doi:10.1016/S0091-679X(06)80004-X 10.1016/S0091-679X(06)80004-X
10. Trounce IA, Kim YL, Jun AS, Wallace DC: Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 1996, 264: 484-509. doi:10.1016/S0076-6879(96)64044-0 10.1016/S0076-6879(96)64044-0
11. Hanson BJ, Capaldi RA, Marusich MF, Sherwood SW: An immunocytochemical approach to detection of mitochondrial disorders. J Histochem Cytochem 2002, 50(10):1281-1288. 10.1177/002215540205001001
12. Cui H, Li F, Chen D, Wang G, Truong CK, Enns GM, Graham B, Milone M, Landsverk ML, Wang J, Zhang W, Wong LJ: Comprehensive next-generation sequence analyses of the entire mitochondrial genome reveal new insights into the molecular diagnosis of mitochondrial DNA disorders. Genet Med 2013, 15(5):388-394. doi:10.1038/gim.2012.144 10.1038/gim.2012.144
13. Zhang W, Cui H, Wong LJ: Comprehensive one-step molecular analyses of mitochondrial genome by massively parallel sequencing. Clin Chem 2012, 58(9):1322-1331. doi:10.1373/clinchem.2011.181438 10.1373/clinchem.2011.181438
14. Dimmock D, Tang LY, Schmitt ES, Wong LJ: Quantitative evaluation of the mitochondrial DNA depletion syndrome. Clin Chem 2010, 56(7):1119-1127. doi:10.1373/clinchem.2009.141549 10.1373/clinchem.2009.141549
15. Weber K, Wilson JN, Taylor L, Brierley E, Johnson MA, Turnbull DM, Bindoff LA: A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet 1997, 60(2):373-380.
16. Pulkes T, Liolitsa D, Nelson IP, Hanna MG: Classical mitochondrial phenotypes without mtDNA mutations: the possible role of nuclear genes. Neurology 2003, 61(8):1144-1147. 10.1212/01.WNL.0000090465.27024.3D
17. Cardaioli E, Da Pozzo P, Radi E, Dotti MT, Federico A: A novel heteroplasmic tRNA(Leu(CUN)) mtDNA point mutation associated with chronic progressive external ophthalmoplegia. Biochem Biophys Res Commun 2005, 327(3):675-678. doi:10.1016/j.bbrc.2004.11.170 10.1016/j.bbrc.2004.11.170
18. Coku J, Shanske S, Mehrazin M, Tanji K, Naini A, Emmanuele V, Patterson M, Hirano M, DiMauro S: Slowly progressive encephalopathy with hearing loss due to a mutation in the mtDNA tRNA(Leu(CUN)) gene. J Neurol Sci 2010, 290(1-2):166-168. doi:10.1016/j.jns.2009.12.001 10.1016/j.jns.2009.12.001
19. Fu K, Hartlen R, Johns T, Genge A, Karpati G, Shoubridge EA: A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy. Hum Mol Genet 1996, 5(11):1835-1840. doi:10.1093/hmg/5.11.1835 10.1093/hmg/5.11.1835
20. Wang J, Brautbar A, Chan AK, Dzwiniel T, Li FY, Waters PJ, Graham BH, Wong LJ: Two mtDNA mutations 14487 T > C (M63V, ND6) and 12297 T > C (tRNA Leu) in a Leigh syndrome family. Mol Genet Metab 2009, 96(2):59-65. doi:10.1016/j.ymgme.2008.10.006 10.1016/j.ymgme.2008.10.006
21. Cardaioli E, Da Pozzo P, Malfatti E, Gallus GN, Rubegni A, Malandrini A, Gaudiano C, Guidi L, Serni G, Berti G, Dotti MT, Federico A: Chronic progressive external ophthalmoplegia: a new heteroplasmic tRNA(Leu(CUN)) mutation of mitochondrial DNA. J Neurol Sci 2008, 272(1-2):106-109. doi:10.1016/j.jns.2008.05.005 10.1016/j.jns.2008.05.005
22. Grasso M, Diegoli M, Brega A, Campana C, Tavazzi L, Arbustini E: The mitochondrial DNA mutation T12297C affects a highly conserved nucleotide of tRNA(Leu(CUN)) and is associated with dilated cardiomyopathy. Eur J Hum Genet 2001, 9(4):311-315. doi:10.1038/sj.ejhg.5200622 10.1038/sj.ejhg.5200622
23. McFarland R, Elson JL, Taylor RW, Howell N, Turnbull DM: Assigning pathogenicity to mitochondrial tRNA mutations: when "definitely maybe" is not good enough. Trends Genet 2004, 20(12):591-596. doi:10.1016/j.tig.2004.09.014 10.1016/j.tig.2004.09.014
24. Gellerich FN, Mayr JA, Reuter S, Sperl W, Zierz S: The problem of interlab variation in methods for mitochondrial disease diagnosis: enzymatic measurement of respiratory chain complexes. Mitochondrion 2004, 4(5-6):427-439. doi:10.1016/j.mito.2004.07.007 10.1016/j.mito.2004.07.007
25. Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR: Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002, 59(9):1406-1411. 10.1212/01.WNL.0000033795.17156.00